• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Equifax Inc.

    5/30/25 4:45:18 PM ET
    $EFX
    Finance: Consumer Services
    Finance
    Get the next $EFX alert in real time by email
    8-K
    EQUIFAX INC false 0000033185 0000033185 2025-05-28 2025-05-28
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 28, 2025

     

     

    EQUIFAX INC.

    (Exact Name of Registrant as Specified in Charter)

     

     

     

    Georgia   001-06605   58-0401110

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    1550 Peachtree Street, N.W.

    Atlanta, Georgia

      30309
    (Address of Principal Executive Offices)   (Zip Code)

    Registrant’s telephone number, including area code: (404) 885-8000

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

      ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

      ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

      ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol

     

    Name of each exchange

    on which registered

    Common stock, $1.25 par value per share   EFX   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On May 30, 2025, Equifax Inc. (the “Company”) announced the departure of Todd Horvath, Executive Vice President, President, U.S. Information Solutions (“USIS”), effective June 1, 2025. The Company has commenced a search for Mr. Horvath’s successor. Chief Executive Officer, Mark Begor, will lead the USIS business unit until a successor is identified.

    In connection with his departure, Mr. Horvath and the Company entered into a separation agreement and general release pursuant to which Mr. Horvath agreed to certain restrictive covenants in favor of the Company. In return for entering into this agreement, Mr. Horvath will receive a lump-sum cash severance payment of $2.9 million, representing approximately two years of his annual cash compensation (minus applicable taxes and withholdings). In addition, the Company agreed that Mr. Horvath will be eligible to receive a prorated portion of his annual incentive award for 2025 reflecting his employment through June 1, 2025. The value of this prorated annual incentive award will be calculated and paid out in the first quarter of 2026 based on the Company’s actual full-year 2025 performance results.

    Mr. Horvath’s unvested equity awards were forfeited upon his separation from the Company. In accordance with the terms of his new hire “make whole” equity award, Mr. Horvath will receive approximately $3.2 million in cash, representing the fair market value of the unvested portion of his new hire equity award at the time of his separation. His new hire equity award was intended to compensate him for foregoing unvested equity at his prior employer.


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      EQUIFAX INC.
        By:  

    /s/ Julia A. Houston

        Name:   Julia A. Houston
        Title:   Executive Vice President and Chief Legal Officer
        Date:   May 30, 2025
    Get the next $EFX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EFX

    DatePrice TargetRatingAnalyst
    4/10/2025$280.00Buy
    BofA Securities
    4/4/2025$260.00Overweight → Equal Weight
    Barclays
    3/20/2025$300.00Sector Perform → Outperform
    RBC Capital Mkts
    3/14/2025$265.00Outperform → Neutral
    Exane BNP Paribas
    2/11/2025Buy → Hold
    Argus
    12/16/2024$305.00Neutral → Outperform
    Exane BNP Paribas
    12/12/2024Outperform → Peer Perform
    Wolfe Research
    12/12/2024$275.00 → $320.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $EFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on Equifax with a new price target

      BofA Securities resumed coverage of Equifax with a rating of Buy and set a new price target of $280.00

      4/10/25 12:41:31 PM ET
      $EFX
      Finance: Consumer Services
      Finance
    • Equifax downgraded by Barclays with a new price target

      Barclays downgraded Equifax from Overweight to Equal Weight and set a new price target of $260.00

      4/4/25 8:36:35 AM ET
      $EFX
      Finance: Consumer Services
      Finance
    • Equifax upgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts upgraded Equifax from Sector Perform to Outperform and set a new price target of $300.00

      3/20/25 7:45:38 AM ET
      $EFX
      Finance: Consumer Services
      Finance